The increasing complexity of pharmaceutical coverage administration systems has intensified the need for automated, intelligent, and self-operating process systems capable of improving efficiency, accuracy, and regulatory compliance. Drug coverage administration involves multiple stakeholders, including regulatory authorities, pharmacy benefit managers (PBMs), healthcare providers, insurers, and data analytics units. Traditional systems rely heavily on manual intervention, fragmented data flows, and rule-based decision-making, leading to inefficiencies, delays, and increased operational costs.

This research explores the conceptual and functional development of self-operating process systems designed to optimize drug coverage administration performance indicators. The study integrates principles from data mining, regulatory analytics, pharmaceutical sampling systems, and robotic process automation (RPA) to propose an advanced hybrid framework. The increasing relevance of automation in healthcare operations is highlighted in recent studies, particularly in PBM quality systems where robotic process automation significantly improves operational accuracy and compliance efficiency (Sravan Kumar Nidiganti, 2025).

The paper synthesizes existing research on drug sampling systems, quality standards, statistical analysis tools, and big data-driven pharmaceutical governance models. It identifies systemic inefficiencies in traditional drug sampling and testing frameworks, including delayed feedback loops, inconsistent regulatory enforcement, and limited predictive capability. By integrating algorithmic decision-making models and process automation systems, the proposed framework aims to enhance key performance indicators such as coverage accuracy, approval turnaround time, cost efficiency, and regulatory compliance rates.

Methodologically, the research employs a conceptual synthesis approach supported by comparative literature analysis and systems modeling. The study further proposes a layered architecture consisting of data acquisition modules, analytical engines, automation workflows, and feedback optimization loops.

Findings indicate that self-operating systems can significantly reduce administrative overhead while improving predictive accuracy in drug coverage decisions. However, challenges remain in data interoperability, system standardization, and regulatory adaptation. The study concludes that intelligent automation, when aligned with pharmaceutical governance frameworks, can transform drug coverage administration into a highly efficient, transparent, and adaptive system.